Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.
Authors
Cooper, Rachel AWest, Catharine M L
Wilks, Deepti P
Logue, John P
Davidson, Susan E
Roberts, Stephen A
Hunter, Robin D
Affiliation
CRC Section of Genome Damage and Repair, Paterson Institute for Cancer Research, Manchester, UK.Issue Date
1999-09
Metadata
Show full item recordAbstract
The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74 patients with locally advanced carcinoma of the cervix. Formalin-fixed, paraffin-embedded tumour biopsies were stained with anti-factor VIII using immunohistochemistry. Vascularity was scored using the intra-tumour microvessel density (IMD), or 'hot-spot', technique. For the same patients, the measurement of intrinsic radiosensitivity (SF2) had been made previously on the same pretherapy samples. Patients were stratified by the median IMD and SF2 scores. Women with radioresistant and highly vascular tumours had poorer 5-year survival (P = 0.0005, P = 0.035 respectively) and local control (P = 0.012, P = 0.077 respectively) than those with radiosensitive and poorly vascular tumours. No significant correlation was seen between IMD and SF2. Multivariate analysis (including tumour stage and patient age) showed that only SF2 and IMD were significant prognostic factors for survival. Patients with both a radioresistant and highly vascular tumour had a 5-year survival level of 18% compared to 77% for those patients with a radiosensitive and poorly vascularized tumour. Tumour angiogenesis and cellular radiosensitivity are independent prognostic factors for cervix carcinoma treated with radiotherapy. Allowing for tumour radiosensitivity increases the prognostic significance of vascularity measurements in cervix tumours.Citation
Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity. 1999, 81 (2):354-8 Br. J. CancerJournal
British Journal of CancerDOI
10.1038/sj.bjc.6690700PubMed ID
10496365Type
ArticleLanguage
enISSN
0007-0920ae974a485f413a2113503eed53cd6c53
10.1038/sj.bjc.6690700
Scopus Count
Related articles
- Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
- Authors: Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM
- Issue date: 2000 Sep
- Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
- Authors: Gasinska A, Fowler JF, Lind BK, Urbanski K
- Issue date: 2004
- Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer.
- Authors: Höckel S, Schlenger K, Vaupel P, Höckel M
- Issue date: 2001 Oct
- Tumor vascularity: a histological measure of angiogenesis and hypoxia.
- Authors: West CM, Cooper RA, Loncaster JA, Wilks DP, Bromley M
- Issue date: 2001 Apr 1
- Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
- Authors: Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY
- Issue date: 2008 Mar